Life Sciences

WBJ sources over the past 35 years have contributed memorable sentiments.

As the biomanufacturing sector continues to expand into a wide range of applications, billions of dollars are being spent on biomedical research, targeting diseases and improving patient outcomes with technology.

The Worcester Business Development Corp., a nonprofit working to support small business owners, has granted U.S. Small Business Administration 504 loans to three companies looking to expand throughout the Northeast.  

Two Central Massachusetts life sciences companies are expanding their presence in the state, committing to a total of 130 new jobs as part of a state tax incentive program designed to bolster the life sciences industry.

Medical device manufacturer Hologic is broadening its focus on women’s health as the Marlborough-based firm has signed a definitive agreement to acquire the California-based medical technology manufacturer Gynesonics. 

The measure would establish licensed facilities where people could buy and take the drugs under supervision, and Bay Staters would also be permitted to grow and use them at home.

The Marlborough-based biotech firm has named Scott Mendel as its new chair of its board of directors.

The biopharma sector could grow the state's GDP by $1 billion over the next five years, though the head of an influential trade group says that boost is contingent on the Legislature approving public aid for the life sciences that's hung up in a stalled economic development bill. 

CELLTREAT Scientific Products, a lab equipment supply company formerly based in Pepperell, has moved its presence to Ayer.

Marlborough-based pharmaceutical company Sumitomo Pharma America has selected executive Kenton Stewart as the firm’s inaugural chief commercial officer, effective Oct. 1.